DRG’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key soft tissue sarcoma patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download. Use the extended worldwide coverage data set to:

  • View 10-year forecasts of the first-line drug-treatable population and diagnosed incident cases of for all 171 countries, stratified by region and World Bank income status.
  • Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.
  • Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
  • Generate and export global heat maps of disease risk or patient population size.

The extended worldwide coverage dashboard is available as an Excel file in the “Downloads” section. It is available only to clients with subscriptions to all 45 countries covered by DRG Epidemiology. For subscription and entitlement queries, please contact questions@teamdrg.com.

Table of contents

  • Extrapolated Worldwide Coverage
    • Extrapolated Worldwide Coverage
      • Soft Tissue Sarcoma Extrapolated Worldwide Coverage

Author(s): Narendra Parihar

Narendra is an associate epidemiologist within the epidemiology team at Decision Resources Group. Narendra specializes in developing epidemiological forecasts for multiple indications within the DRG syndicated portfolio. His qualifications include an MPH with specialization in Health Policy, Economics and Finance from the Tata Institute of Social Sciences, Mumbai, and a Bachelor’s degree in Dentistry from the Rajasthan University of Health Sciences.


Related Reports

Soft Tissue Sarcoma | Epidemiology | Epidemiology Dashboard

DRG Epidemiology’s coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence...

View Details

Soft Tissue Sarcoma | Epidemiology | Americas

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across the Americas (Argentina, Canada, Chile, Colombia, and Peru). We report...

View Details

Soft Tissue Sarcoma | Epidemiology | Europe

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across Europe (Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Ne...

View Details

Soft Tissue Sarcoma | Epidemiology | Emerging Markets

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across the Emerging Markets (Brazil, China, India, Mexico, Russia, South...

View Details